[25-006565] nhlbi sequencing core facility requires illumina kits and reagents in order to carry out next-generation sequencing on illumina instruments for supported investigators.
Ended Awarded Last action
- Contract number
- 75N92025F00003
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,678
Award facts
- Contract value 100% obligated
- $14,678.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1 | |
| Original award | $14,679 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $14,678.10 to Illumina, Inc. for next-generation sequencing (NGS) kits and reagents. This firm fixed-price contract, issued on February 27, 2025, with an ultimate completion date of December 11, 2025, will support the NHLBI Sequencing Core Facility in conducting genomic analysis on Illumina instruments for research investigators. The award carries no set-aside designation, reflecting Illumina's specialized capabilities as the sole manufacturer of the compatible sequencing platforms and consumables required for the facility's operations. Performance will occur at Illumina's San Diego, California location.
As a delivery order under a larger indefinite delivery vehicle, this award represents a specific task order for consumable supplies essential to the NHLBI's genomic research infrastructure. Illumina's provision of sequencing kits and reagents enables the core facility to execute high-throughput DNA and RNA sequencing projects that support the Institute's mission in cardiovascular, pulmonary, and hematological research. The relatively modest ceiling value reflects the consumable nature of the procurement, with such delivery orders typically executed on an as-needed basis to maintain continuous laboratory operations and support the research agenda of funded investigators across the NHLBI's scientific programs.
Quick answers
Who was awarded contract 75N92025F00003?
75N92025F00003 was awarded to Illumina, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 27, 2025.
How much is contract 75N92025F00003 worth?
The government has obligated $14,678 on 75N92025F00003.
Is contract 75N92025F00003 an order under another contract?
Yes. 75N92025F00003 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92025F00003 competed?
The extent of competition for 75N92025F00003 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award